TRENDS IN NINTEDANIB AND PIRFENIDONE UTILIZATION FOR IDIOPATHIC PULMONARY FIBROSIS IN AUSTRALIA

被引：0

作者：

Cox, I ^{[1
,2
]}

De Graaff, B. ^{[1
,2
]}

Corte, T. ^{[2
,3
,4
]}

Glaspole, I ^{[2
,5
,6
]}

Chambers, D. ^{[2
,7
,8
]}

Moodley, Y. ^{[2
,9
,10
,11
]}

Teoh, A. ^{[2
,4
]}

Walters, E. ^{[1
,2
]}

Palmer, A. ^{[1
,2
,12
]}

机构：

[1] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia

[2] NHMRC Ctr Res Excellence Pulm Fibrosis, Sydney, NSW, Australia

[3] Univ Sydney, Cent Clin Sch, Camperdown, NSW, Australia

[4] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Camperdown, NSW, Australia

[5] Alfred Hosp, Melbourne, Vic, Australia

[6] Monash Univ, Melbourne, Vic, Australia

[7] Univ Queensland, Sch Clin Med, Brisbane, Qld, Australia

[8] Prince Charles Hosp, Queensland Lung Transplant Serv, Brisbane, Qld, Australia

[9] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA, Australia

[10] Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia

[11] Fiona Stanley Hosp, Dept Resp Med, Murdoch, WA, Australia

[12] Univ Melbourne, Sch Populat & Global Hlth, Ctr Hlth Policy, Melbourne, Vic, Australia

来源：

基金：

英国医学研究理事会;

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

TO 141

引用

页码：92 / 92

页数：1